Literature DB >> 27031474

High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms1.

Anne M Koivisto1,2, Mitja I Kurki3, Irina Alafuzoff4, Anna Sutela5, Jaana Rummukainen6, Sakari Savolainen3, Ritva Vanninen5,7, Juha E Jääskeläinen3,8, Hilkka Soininen1,2, Ville Leinonen3,8.   

Abstract

BACKGROUND: Differential diagnosis of ventricular enlargement with normal pressure hydrocephalus (NPH) related symptoms is challenging. Patients with enlarged ventricles often manifest cognitive deterioration but their long-term outcome is not well known.
OBJECTIVES: We aim to evaluate long-term cognitive outcome in patients with enlarged ventricles and clinically suspected NPH.
METHODS: A neurologist and a neurosurgeon clinically evaluated 468 patients with enlarged ventricles and suspected NPH using radiological methods, intraventricular pressure monitoring, and frontal cortical brain biopsy. The neurologist confirmed final diagnoses after a median follow-up interval of 4.8 years.
RESULTS: Altogether, 232 patients (50%) with enlarged ventricles did not fulfill the criteria for shunt surgery. The incidence of dementia among patients with enlarged ventricles, and at least one NPH-related symptom with adequate follow-up data (n = 446) was high, varying from 77 (iNPH, shunt responders) to 141/1000 person-years (non-shunted patients with enlarged ventricles). At the end of the follow-up, 59% of all these patients were demented. The demented population comprised 73% of non-shunted patients with enlarged ventricles, 63% of shunted iNPH patients that did not respond to treatment, and 46% of iNPH patients that were initially responsive to shunting. The most common cause of dementia was Alzheimer's disease (n = 94, 36%), followed by vascular dementia (n = 68, 26%).
CONCLUSIONS: One-half of patients with enlarged ventricles and clinically suspected NPH were not shunted after intraventricular pressure monitoring. Dementia caused by various neurodegenerative diseases was frequently seen in patients with ventricular enlargement. Thus, careful diagnostic evaluation in collaboration with neurologists and neurosurgeons is emphasized.

Entities:  

Keywords:  Alzheimer’s disease; cognition; dementia; memory; normal pressure hydrocephalus; prognosis; vascular dementia; ventricular enlargement

Mesh:

Year:  2016        PMID: 27031474     DOI: 10.3233/JAD-150909

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

Review 1.  Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case.

Authors:  V E Korhonen; E Solje; N M Suhonen; T Rauramaa; R Vanninen; A M Remes; V Leinonen
Journal:  Fluids Barriers CNS       Date:  2017-04-19

2.  Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease.

Authors:  Sylwia Libard; Irina Alafuzoff
Journal:  Acta Neuropathol Commun       Date:  2019-05-29       Impact factor: 7.801

3.  The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients.

Authors:  A Junkkari; A J Luikku; N Danner; H K Jyrkkänen; T Rauramaa; V E Korhonen; A M Koivisto; O Nerg; M Kojoukhova; T J Huttunen; J E Jääskeläinen; V Leinonen
Journal:  Fluids Barriers CNS       Date:  2019-07-25

4.  Long-Term Prognosis of Cognitive Function in Patients With Idiopathic Normal Pressure Hydrocephalus After Shunt Surgery.

Authors:  Akihiro Kambara; Yoshinaga Kajimoto; Ryokichi Yagi; Naokado Ikeda; Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Toshihiko Kuroiwa; Kenji Kuroda; Shohei Tsuji; Ryuichi Saura; Masahiko Wanibuchi
Journal:  Front Aging Neurosci       Date:  2021-01-20       Impact factor: 5.750

5.  Prevalence of Schizophrenia in Idiopathic Normal Pressure Hydrocephalus.

Authors:  Vasco Vanhala; Antti Junkkari; Ville E Korhonen; Mitja I Kurki; Mikko Hiltunen; Tuomas Rauramaa; Ossi Nerg; Anne M Koivisto; Anne M Remes; Jonna Perälä; Jaana Suvisaari; Soili M Lehto; Heimo Viinamäki; Hilkka Soininen; Juha E Jääskeläinen; Ville Leinonen
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.